Skoka develops patent pending oral nicotine pouches tailored for professional athletes and active lifestyles.
Skoka has raised $21.5M in total funding. The most recent round was Angel. The last funding was announced in October 2026.
Skoka's investors include Anthony Kim, Dylan Larkin, Scottie Upshall, Mark Hastings, Darren Throop.
Skoka is headquartered in Boston, United States.
Skoka develops patent pending oral nicotine pouches tailored for professional athletes and active lifestyles.
Skoka is at the Angel stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Skoka — Funding & Investors." VCBacked, October 29, 2026, https://www.vcbacked.co/company/skoka. Accessed November 2, 2026.
VCBacked. (2026). Skoka — Funding & Investors. Retrieved November 2, 2026, from https://www.vcbacked.co/company/skoka
{{cite web |title=Skoka — Funding & Investors |url=https://www.vcbacked.co/company/skoka |website=VCBacked |access-date=November 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Skoka? Request a listing update